COMP <GO>
CRH vs TMO // FREE CASH FLOW YIELD
CRH PLC (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CRH 8
— TMO 7
▲ FREE CASH FLOW YIELD LEADER: CRH
LAST: $90.81 (+0.21%) • MKT CAP: $60.29B
fcf-yield
4.83%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
fcf-yield
2.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRH VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRH | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.10% | 41.00% | -4.90 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.80% | 9.30% | +2.50 | CRH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.4x | 30.4x | -21.00 | CRH | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.83% | 2.40% | +2.43 | CRH | /fcf-yield <GO> |
| Operating Margin | 14.50% | 17.40% | -2.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.00% | 15.10% | -5.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 5.30% | 3.90% | +1.40 | CRH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.80 | 4.50 | -1.70 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | CRH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.70% | -0.20 | CRH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.2 | 59.1 | +7.01 | CRH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.94 | -0.05 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.0x | 36.3x | -21.30 | CRH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $60.29B | $262.22B | -$201.93B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRH REV | TMO REV | CRH GROSS % | TMO GROSS % | CRH FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $37.45B | $44.56B | 36.1% | 44.0% | $2.91B | $6.29B |
| FY 2024 | $35.57B | $42.88B | 35.7% | 44.0% | $2.41B | $7.27B |
| FY 2023 | $34.95B | $42.86B | 44.0% | 44.0% | $3.44B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRH // BETA 0.89
TMO // BETA 0.94